Direkt zum Inhalt
Merck
  • A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.

A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.

Cell cycle (Georgetown, Tex.) (2014-12-09)
Elena Kurenova, Deniz Ucar, Jianqun Liao, Michael Yemma, Priyanka Gogate, Wiam Bshara, Ulas Sunar, Mukund Seshadri, Steven N Hochwald, William G Cance
ZUSAMMENFASSUNG

Melanoma has the highest mortality rate of all skin cancers and a major cause of treatment failure is drug resistance. Tumors heterogeneity requires novel therapeutic strategies and new drugs targeting multiple pathways. One of the new approaches is targeting the scaffolding function of tumor related proteins such as focal adhesion kinase (FAK). FAK is overexpressed in most solid tumors and is involved in multiple protein-protein interactions critical for tumor cell survival, tumor neovascularization, progression and metastasis. In this study, we investigated the anticancer activity of the FAK scaffold inhibitor C4, targeted to the FAK-VEGFR-3 complex, against melanomas. We compared C4 inhibitory effects in BRAF mutant vs BRAF wild type melanomas. C4 effectively caused melanoma tumor regression in vivo, when administered alone and sensitized tumors to chemotherapy. The most dramatic effect of C4 was related to reduction of vasculature of both BRAF wild type and V600E mutant xenograft tumors. The in vivo effects of C4 were assessed in xenograft models using non-invasive multimodality imaging in conjunction with histologic and molecular biology methods. C4 inhibited cell viability, adhesion and motility of melanoma and endothelial cells, specifically blocked phosphorylation of VEGFR-3 and FAK and disrupted their complexes. Specificity of in vivo effects for C4 were confirmed by a decrease in tumor FAK and VEGFR-3 phosphorylation, reduction of vasculogenesis and reduced blood flow. Our collective observations provide evidence that a small molecule inhibitor targeted to the FAK protein-protein interaction site successfully inhibits melanoma growth through dual targeting of tumor and endothelial cells and is effective against both BRAF wild type and mutant melanomas.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Dimethylsulfoxid, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Dimethylsulfoxid, ACS reagent, ≥99.9%
Sigma-Aldrich
Dimethylsulfoxid, for molecular biology
Sigma-Aldrich
Dimethylsulfoxid, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimethylsulfoxid, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Dimethylsulfoxid, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Dimethylsulfoxid, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
Dimethylsulfoxid, BioUltra, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
Ethylendiamintetraessigsäure -Lösung, 0.02% in DPBS (0.5 mM), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Ethylendiamintetraessigsäure, anhydrous, crystalline, BioReagent, suitable for cell culture
Sigma-Aldrich
Ethylendiamintetraessigsäure, 99.995% trace metals basis
Sigma-Aldrich
Anti-Phosphotyrosin-Antikörper, Klon 4G10®, clone 4G10®, Upstate®, from mouse
Sigma-Aldrich
Dimethylsulfoxid, anhydrous, ≥99.9%
Sigma-Aldrich
Dimethylsulfoxid, PCR Reagent
Sigma-Aldrich
Ethylendiamintetraessigsäure, ACS reagent, 99.4-100.6%, powder
Sigma-Aldrich
Isopropyl-β-D-thiogalactopyranosid -Lösung, ReadyMade IPTG solution for Blue-white screening
Sigma-Aldrich
IPTG, ≥99% (TLC), ≤0.1% Dioxane
Sigma-Aldrich
Ethylendiamintetraessigsäure Dinatriumsalz -Lösung, BioUltra, for molecular biology, pH 8.0, ~0.5 M in H2O
USP
Dimethylsulfoxid, United States Pharmacopeia (USP) Reference Standard
SAFC
Isopropyl β-D-1-Thiogalactopyranosid
Sigma-Aldrich
Ethylendiamintetraessigsäure, anhydrous, BioUltra, ≥99% (titration)
Sigma-Aldrich
Isopropyl β-D-1-Thiogalactopyranosid, ≥99% (TLC)
Sigma-Aldrich
O-Phospho-L-Tyrosin
Sigma-Aldrich
Ethylendiamintetraessigsäure, purified grade, ≥98.5%, powder
Sigma-Aldrich
Dimethylsulfoxid, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
Dacarbazin, antineoplastic purine analog
Sigma-Aldrich
Anti-Paxillin-Antikörper, Klon 5H11, clone 5H11, Upstate®, from mouse
Sigma-Aldrich
Ethylendiamintetraessigsäure, ≥98.0% (KT)
Sigma-Aldrich
8-Octanoyloxypyren-1,3,6-Trisulfonsäure Trinatriumsalz, suitable for fluorescence, ≥90% (HPCE)
Supelco
Dimethylsulfoxid, analytical standard